YDYujiang Dong

Yujiang Dong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yujiang Dong has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Lu Fan

    Department of Hematology, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

    1 shared publication
  • Rui Wu

    Pingyi County Hospital of Traditional Chinese Medicine Cardiology Department , Linyi , 273300 , China

    1 shared publication
  • Weiying Bao

    Department of Hematology, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

    1 shared publication
  • Wenwu Li

    Department of Burn Plastic and Wound Repair Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China

    1 shared publication
  • Yuelong Qin

    First Clinical Medical College, Shandong University of Traditional Chinese Medicine , Jinan , 250000 , China

    1 shared publication
  • Zhenzhen Zhao

    The First Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan, China

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    Decoding multiple myeloma: single-cell insights into tumor heterogeneity, immune dynamics, and disease progression

    by Zhenzhen Zhao, Zhijie Zhao, Zhiheng Lin, Lu Fan, Zhikai Xiahou, Yujiang Dong, Weiying Bao

    Background: Multiple myeloma (MM) is a biologically heterogeneous malignancy of clonal plasma cells, often progressing from MGUS or smoldering MM. It causes anemia, bone lesions, and immune dysfunction due to abnormal plasma cell expansion in the bone marrow. Neuroinflammatory and neurotrophic factors may influence MM progression by affecting immune cells and the bone marrow niche. Growing evidence points to a role for neuroimmune regulation in tumor immunity. Despite therapeutic progress, disease heterogeneity and resistance highlight the need for new strategies targeting the tumor microenvironment and neuroimmune axis.Methods: This investigation exploited single-cell RNA sequencing (scRNA-seq) to analyze MM and high-risk smoldering multiple myeloma (SMMh) samples, identifying 11 distinct cell types. We examined their transcriptional signatures, stemness, proliferative properties, and metabolic pathways, with particular attention to neuroimmune interactions in the tumor microenvironment. Using trajectory inference tools such as CytoTRACE, Monocle2, and Slingshot, we traced the differentiation paths of MM cell subpopulations and identified key signaling pathways that may influence immune responses and tumor progression.Results: The analysis identified four distinct subpopulations of myeloma cells, with the C0 IGLC3+ myeloma cells representing the least differentiated and most proliferative subset. These cells played a critical role in MM progression and may contribute to immune evasion mechanisms. Additionally, receptor-ligand interactions within the tumor microenvironment were identified, which may be influenced by neuroinflammatory and neurotrophic factors. These findings suggest that the nervous system and immune modulation significantly affect tumor biology, highlighting potential therapeutic targets that could be exploited to overcome resistance to conventional therapies.Conclusion: This single-cell analysis provided new insights into the cellular diversity and differentiation trajectories in MM, offering a deeper understanding of the complex neuroimmune interactions that drive tumor progression and resistance. By incorporating the role of neuroinflammation and immune modulation, our study suggested novel therapeutic strategies targeting the neuroimmune axis in oncology, ultimately contributing to the development of more effective, personalized treatment approaches for MM.


  • Open Access

    Single-cell analysis identified key macrophage subpopulations associated with atherosclerosis

    by Zhenzhen Zhao, Yuelong Qin, Rui Wu, Wenwu Li, Yujiang Dong

    Background: Atherosclerosis is a lipid-driven inflammatory disease characterized by plaque formation in major arteries. These plaques contain lipid-rich macrophages that accumulate through monocyte recruitment, local macrophage differentiation, and proliferation. Objective: We identify the macrophage subsets that are closely related to atherosclerosis and reveal the key pathways in the progression of atherosclerotic disease. Materials and methods: In this study, we characterize the single-cell landscape of atherosclerosis, identifying macrophage subsets closely related to the disease and revealing key pathways in its progression. Using analytical methods like CytoTRACE, Monocle2, Slingshot, and CellChat, we study macrophage differentiation and infer cell trajectory. Results: The 8,417 macrophages were divided into six subtypes, macrophages: C0 C1QC+ macrophages, C1 SPP1+ macrophages, C2 FCN1+ macrophages, C3 IGKC+ macrophages, C4 FCER1A+ macrophages, C5CALD1+ macrophages. The results of gene set enrichment analysis, Monocle2, and Slingshot suggest that C2 FCN1+ macrophages may play an important role in the progression of atherosclerosis. C2 FCN1+ macrophages interact with endothelial cells via CCL, CXCL, APP, and other pathways to regulate the progression of atherosclerosis. Conclusion: We identify a key macrophage subgroup (C2 FCN1+ macrophages) associated with atherosclerosis, which interacts with endothelial cells via CCL, CXCL, APP, and other pathways to regulate disease progression.